A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy
- Abbreviated Name
- PCGEM1 and PCA3 noncoding RNAs
- Lead Investigator
- Chesnut, Gregory — Center for Prostate Disease Research Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center
- Coordinating Investigator
- Chesnut, Gregory — Center for Prostate Disease Research Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center
- Involved Investigators
Abstact
No abstract availalbe.
Aims
1. To present the development and optimization of a noninvasive, first catch, nonDRE urine based sensitive gene expression assay 2. To define a CaP gene panel that can discriminate GS 7-10 from GS 6 (3D3) and benign disease before biopsy; IRB #WU IRB No. 11-7487
Analytic Method
ddPCR
Publications
- No publications available at this time for this protocol.
Biomarkers
- No biomarkers available at this time for this protocol.
Data Collections
- No data collections available at this time for this protocol.
Team Project
- Protocol ID
- 484
- Protocol Type
- Single
- Field of Research
- Genomics
- Collaborative Group
- Prostate and Urologic Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of prostate
- Phased Status
- 2